Golden
Janus Henderson Investors

Janus Henderson Investors

An investment management firm specializing in long-term financial management.

Janus Henderson Investors is an investment management firm specializing in long-term financial management that is headquartered in Denver, Colorado and was founded in 2017 during the merger of Janus Capital Group and Henderson Global Investors. The firm offers a variety of financial products such as ETFs, managed accounts, and mutual funds that are focused on different asset classes such as alternatives, equities, fixed income, and multi-asset. The firms investment products have an investment focus on emerging markets, global, international, and United States markets.

Janus Henderson Investors also offers advisory services for client acquisition, client loyalty, team and personal effectiveness, fiduciary & regulatory, and portfolio strategy.

Timeline

Funded Companies

Company
Description
Website
Industry
Location

BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.

An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.

Magic Leap is an augmented reality company developing hardware and software for enhanced AR experience.

4D Molecular Therapeutics designs, develops and commercializes products for gene therapy.

BridgeBio Pharma is a Palo Alto, California-based company.

Akero Therapeutics is a Cambridge, Massachusetts-based company.

7 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Dick Weil

Chief Executive Officer

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

News

Title
Author
Date
Publisher
Description
Sujata Rao
March 10, 2020
U.S.
For money managers, it's bad enough watching the coronavirus wipe trillions of dollars off world markets' value. Even worse is not knowing how bad the outbreak really is for the economy, company balance sheets, and in turn for their portfolios.

References